All articles by Luke Christou

  1. How to prevent contamination in a biopharmaceutical manufacturing operation

    Unlike traditional pharmaceuticals, biopharmaceuticals are a result of the genetic manipulation of living cells. Developing these extremely complex structures comes…
    Read More…

    4 Feb
  2. Should pharmaceutical manufacturers invest in single-use containment?

    In an industry where safety is of the utmost importance ILC Dover’s single-use systems offer some of the most advanced…
    Read More…

    4 Feb
  3. Flexible powder containment: ILC Dover’s DoverPac system

    DoverPac is a flexible containment system developed by engineering development and manufacturing company ILC Dover in collaboration with global pharmaceutical…
    Read More…

    5 Dec
  4. Effective containment systems for high potency active pharmaceutical ingredients (HP APIs)

    The rules and regulations that pharmaceutical manufacturers must follow largely vary between regulatory agencies. However, there is one thing that…
    Read More…

    22 Nov
  5. How CMOs can benefit from single-use solutions

    Pharmaceutical companies are increasingly turning to contract manufacturing organisations (CMOs) to make their products, which frees up more time and…
    Read More…

    24 Sep
  6. The high cost of contamination in drugs manufacturing

    Pharmaceuticals is one of the highest value industries globally, with 28 of the 1,000 largest companies in the world by…
    Read More…

    12 Sep
  7. How safe is your process? The usual causes of pharmaceutical contamination

    Large-scale plant shutdowns are somewhat rare in the pharmaceutical industry, given the high level of care that manufacturers must take…
    Read More…

    17 Aug
  8. ILC Dover flexible isolators: A cost-effective way to maximise containment

    High potency active pharmaceutical ingredients (HP APIs) are the fastest growing segment of the API market.  This is mainly due…
    Read More…

    17 Aug

Go Top